The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The CDK4/6 inhibitor FCN-437c plus letrozole for the treatment of HR+/HER2– advanced breast cancer: Updated results from a phase 1b study.
 
Jian Zhang
No Relationships to Disclose
 
Xiaojia Wang
No Relationships to Disclose
 
Xian Wang
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Tao Huang
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Ai-Min Hui
Employment - Fosun Pharma
Leadership - Fosun Pharma
 
Zhuli Wu
Employment - Fosun Pharma
Leadership - Fosun Pharma
 
Ling Tian
Employment - Avacta Life Sciences
 
Han Zhao
Employment - Fosun Pharma
 
Yuchen Yang
Employment - Fosun Pharma
 
Wenjing Zhang
Employment - Fosun Pharma
 
Yushun Zhang
Employment - Fosun Pharma
 
Xichun Hu
No Relationships to Disclose